Abstract
The debate over whether the U.S. Food and Drug Administration (FDA) should regulate laboratory developed tests continues to divide experts in the clinical diagnostics community. However, this issue was but one of many under lively discussion during the 31st annual Clinical Virology Symposium (CVS), held last April in Daytona Beach, Fla.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
